Srikanth Reddy Janga
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 28, 2020
Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.Yaping Ju, Maria C Edman, Hao Guo
|Aug 14, 2019
Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.Yaping Ju, Hao Guo, Frances Yarber
|Jul 04, 2019
Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.Wannita Klinngam, Srikanth R Janga, Changrim Lee
|May 17, 2019
Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.Changrim Lee, Hao Guo, Wannita Klinngam
|Nov 15, 2018
Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.Wannita Klinngam, Runzhong Fu, Srikanth R Janga
|Aug 22, 2018
Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.Srikanth R Janga, Mihir Shah, Yaping Ju
Pageof 2
